The GMP Letter
October 2012
Official: FDA Guidance on Recalls Versus Enhancements Coming
The FDA plans to issue clarifying guidance to address confusion among devicemakers about what exactly constitutes an enhancement and what qualifies as a recall, a CDRH official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|